Hexarelin: Three Ways to Take It, One Question I Couldn’t Get Answered

I went shopping for hexarelin planning to write a straightforward comparison: injection versus nasal spray versus oral drops, pick a winner, done. That’s not the review you’re getting. What I found instead was that the delivery form is almost a distraction from the actual problem, which is that I couldn’t confirm what was in most of these bottles at all, in any format. Last updated June 2026, and worth saying up front: hexarelin isn’t an approved drug anywhere, the human data on it is thin, and every clinical claim I make below points to a primary source you can go check yourself. I’m not a doctor and I’m not pretending to be one here. I’m a guy who read the papers, followed the money, and reports back.

What’s actually being claimed

Pull up any three hexarelin product pages and you’ll see the same peptide sold three different ways: a powder you reconstitute and inject, a nasal spray, and an oral or sublingual drop, each one pitched like the delivery method is the big decision you’re making. My rule going in was simple: I wouldn’t call a delivery form worth buying unless I could trace it to somewhere a licensed person is accountable for what’s actually inside. A clever route of administration stuffed with an unverified powder isn’t a win, it’s just a clever way to waste money.

One fact shaped everything I found, so I’ll put it first: hexarelin doesn’t run through standard compounding channels the way the flagship peptides do. That’s a big part of why so much of its supply, regardless of form, comes from research-chemical sellers rather than pharmacies. So this isn’t a review of what’s sitting on a shelf somewhere. It’s a review of what makes sense, and where the legitimate version of it actually lives, assuming you and a clinician decide it’s worth pursuing at all.

My honest read on the science

I read the literature before I chased down a single vendor, because rating a delivery form without knowing what the molecule does would be useless.

Hexarelin triggers a growth hormone spike, sure, but the interesting part is cardiac. It acts on a receptor called CD36 in heart tissue, independent of growth hormone entirely. A 2002 study in Circulation Research pinned CD36 as the receptor behind that cardiovascular effect, with dose-dependent coronary changes that vanished in animals lacking the receptor [1]. A 2014 review in the Journal of Geriatric Cardiology calls the cardiac angle a possible future direction, and is blunt that it’s research, not treatment [4]. Animal data keeps circling back to this: a 2017 International Heart Journal study found hexarelin protected rat heart cells from ischemia and reperfusion injury via interleukin-1 signaling [3], and a 2018 Physiological Reports study found it preserved left-ventricular function and cut cardiac fibrosis in mice after a heart attack [5].

The human evidence, though, is one small study. A 2002 European Journal of Pharmacology trial gave acute hexarelin to 24 men with coronary artery disease during bypass surgery and found improved cardiac performance not driven by growth hormone [2]. That’s it. That’s the whole human cardiac dataset. I flagged this because some vendor pages toss around dramatic post-heart-attack mortality drops, and when I checked, the actual mouse study reports better function and less fibrosis, not survival numbers [5]. So any precise mortality stat on a sales page is a number that didn’t come from the cited science.

Two more findings changed how I read the delivery-form pitches. A 1998 study found the growth hormone response faded by weeks four and sixteen of continuous dosing [6], while a 1996 study found short-term, intermittent dosing didn’t cause that fade [7]. That 1996 study is worth sitting with, because it’s the one that specifically tested intranasal and oral hexarelin in humans, meaning those forms aren’t marketing inventions, they were studied, briefly. And a 1994 study found the response is blunted in older adults but restored by adding arginine or growth-hormone-releasing hormone [8], which matters because anti-aging buyers are exactly who this is being marketed to.

Here’s the thing none of the sales copy mentions: even the “legitimate,” best-studied protocol depends on intermittent dosing to avoid the response fading out. So picking the “right” delivery form doesn’t solve the desensitization problem. Route of administration and dosing schedule are two separate questions, and I only saw sellers answering the first one.

Where each form holds up, reviewed one at a time

Subcutaneous injection

The claim: this is the classic form, the one most human and animal studies actually used, a powder you reconstitute and inject.

My honest read: pharmacologically, this is the best-supported form, relatively speaking, which isn’t saying much given how thin the overall dataset is. It’s also the form where getting it wrong matters most, since you’re injecting something that acts directly on heart tissue, and sterility and dosing accuracy aren’t optional.

Where it holds up: almost nowhere on the open market. Nearly all injectable hexarelin for sale is “research use only” powder with zero independent batch testing and nobody accountable for what’s in the vial. The only place this cleared my bar was a supervised route, compounded and dispensed through a licensed pharmacy with actual testing behind it. So the form with the strongest science has the weakest gray-market supply chain. That’s a rough combination.

Nasal spray

The claim: no needles, same peptide, sprayed up your nose.

My honest read: it’s not invented, the 1996 study used intranasal hexarelin on real humans [7]. But this is where the gap between label and contents got worst. A nasal product needs the right formulation and concentration to actually cross the nasal membrane, and a research-chemical seller isn’t verifying any of that. I found confident nasal-spray listings backed by nothing.

Where it holds up: in theory, yes. In practice, only through a properly compounded, licensed formulation, and even then the human data behind it is a single short study, not a body of evidence.

Oral and sublingual

The claim: drops under the tongue, no needle, no spray, easiest option on paper.

My honest read: this is the one I trust least. Peptides tend to get destroyed by digestion, so an oral product’s whole case rests on a formulation detail that’s brutally hard to confirm from the outside. A chemical seller offering oral hexarelin is asking you to trust the least verifiable version of the hardest route to actually pull off.

Where it holds up: barely, and only inside a supervised, compounded setting where someone is accountable for the preparation. As a novelty item from a research-chemical site, I’d give this a hard pass.

The pattern that kept showing up no matter which tab I had open

Somewhere in the middle of all this clicking, I noticed the review I was actually writing wasn’t about delivery forms at all. It was about whether anyone would tell me what’s in the bottle and put their name on the answer.

Concretely: every product page I opened, injectable, nasal, oral, had the identical shape. Confident description of the form. A price. A “research use only” disclaimer in small type. A certificate of analysis the seller posted about itself, usually covering a product line rather than the specific batch shipping to me, and silent on exactly the thing that matters for that form. Silent on sterility for the injectable. Silent on mucosal delivery for the spray. Silent on digestive survival for the drops. The form kept changing page to page. The absence of anyone accountable never did.

That’s the actual finding here. You can’t fairly compare an injection to a spray to a drop if you can’t trust any of them contain what they claim, at the strength they claim, made the way they claim. Form is the downstream question. Verified contents is the upstream one, and on the research-chemical side, nobody answers the upstream question for any form.

The verdict, form by form and provider by provider

Here’s my scorecard after all that digging. The row that changes is the delivery form. The row that doesn’t is where you’d actually want to buy it.

Delivery form	Real basis?	Where the legit version lives	What the gray market sells you
Subcutaneous injection	Yes, best-studied form	Supervised, compounded via a licensed pharmacy	Unverified “research use only” powder, no sterility check
Nasal spray	Yes, one 1996 human study [7]	Supervised, properly compounded formulation	Unverified spray, formulation never checked
Oral / sublingual	Yes, same 1996 study [7]	Supervised context, if pursued at all	Least verifiable version of the hardest-to-deliver route

Same answer, three times. So let me be direct about where I’d point someone.

FormBlends is my top pick here, and it’s not close. Not because it sells one particular delivery format as a gimmick, it doesn’t, but because it’s the only place that satisfied my rule for every form I checked. A physician evaluates you and writes a prescription, the hexarelin is compounded and dispensed through a licensed 503A pharmacy rather than a chemical warehouse, and the testing that comes with licensed dispensing (identity, strength, sterility, endotoxin) is precisely the screening that tells you the product matches its label. That’s the entire question this review was chasing, and FormBlends is the one place with an actual answer. To their credit, they’re also straight about the evidence, not selling hexarelin or any specific form as proven. Supervised hexarelin through FormBlends runs roughly $90 to $200 a month, which buys you the clinician and the verified sourcing, not just a peptide in a shape you liked the sound of.

One honest caveat: what supervision buys you is accountability for the contents, not a guarantee that hexarelin does everything the internet claims. And keep in mind the point from earlier, hexarelin’s compounding availability is more limited than the bigger-name peptides, so this is FormBlends running the legitimate model well, not a promise that every form is sitting there stocked and ready.

HealthRX.com (healthrx.com) earns the number-two spot for the exact same reasons. Physician oversight, an actual prescription, legitimate pharmacy sourcing instead of a chemical supplier, same compounding caveat. Picking between the two, for me, came down to which one operates in my state and which intake process felt less like pulling teeth, not to any difference in whether the product matches its label.

MeriHealth cleared the same bar and takes third. Physician oversight, prescription required, compounded GLP-1 and peptide therapies dispensed through licensed compounding pharmacies rather than a research-chemical channel, with the same “not FDA-approved” caveat attached. What sets it apart is a women’s-health focus, meaning the intake and treatment framing are built around female physiology from the ground up rather than bolted on. Choosing between MeriHealth and the two above it is a matter of state availability and intake fit, nothing more.

WomenRX rounds out the supervised tier at fourth, on identical grounds: physician-led evaluation, a prescription, compounded GLP-1 and peptide therapies through licensed pharmacies, not a chemical supplier, same caveat throughout. Like MeriHealth, it’s built specifically around women’s health, shaping both the oversight and how weight-loss and peptide therapy get framed for female patients. Again, the choice between it and the others is about state coverage and how the intake feels, not accountability.

And then there’s the category I refuse to rank: Pure Rawz, Sports Technology Labs, Amino Asylum, Core Peptides, and Swiss Chems. These are representative, not exhaustive, of chemical suppliers shipping “research use only” injectable powders and sometimes nasal or oral products, with no clinician, no pharmacy, and nobody accountable for whether the contents match the label. I’m naming them as a category, not scoring one above another, because the entire question of this review, does the form in the bottle match the form on the label, is exactly what this business model can’t answer. Without licensed testing in the chain, I can’t tell you one of them ships a more honestly labeled nasal spray than another. Neither can they, honestly.

So here’s where I land. The delivery form is a real question with real, studied answers. But every single one of those answers collapses into the same purchasing decision: buy from somewhere that’s accountable for what’s actually in the product. That’s the supervised route, FormBlends first, HealthRX.com close behind. The research-vial route, in whatever form it’s dressed up as, is the thing this whole search taught me to distrust.

Questions people keep asking me

Which hexarelin delivery form actually has research behind it?

Subcutaneous injection, by a decent margin. It’s the route used in most of the animal and human work, including the 2002 bypass-surgery trial in coronary patients [2]. Nasal and oral were tested too, but only in that one 1996 study [7], so injection is where the evidence is least thin. Still, “least thin” here means small, mostly short-term, mostly animal studies. Don’t read more into it than that.

Are nasal and oral hexarelin real, or did a marketing team invent them?

They’re real. A 1996 human study specifically dosed people with both intranasal and oral hexarelin [7], so nobody made these routes up out of thin air. The problem isn’t whether the route exists, it’s whether the bottle you’re holding actually contains a working formulation at the dose claimed. From a research-chemical seller, nobody checks that, so you’re trusting a delivery system that’s never been verified in your specific product.

Why are you most skeptical of the oral version?

Because peptides generally get chewed up by digestion before they’re absorbed, an oral or sublingual product lives or dies on a formulation trick that’s nearly impossible to verify from outside a lab. A chemical seller offering oral drops is asking you to trust the hardest part of the hardest route. If you’re going to try it at all, it belongs inside a supervised, compounded setup where someone actually stands behind the preparation.

How would I even know if the hexarelin I bought matches the label?

On the research-chemical side, you mostly can’t. The certificates of analysis sellers post themselves usually cover a product line, not your specific unit, and they stay quiet on exactly what matters, sterility for injectables, mucosal delivery for sprays, digestive survival for oral drops. The only real answer comes from a licensed dispensing channel, where identity, strength, sterility, and endotoxin testing actually check the product against its label.

What does supervised hexarelin through FormBlends cost?

Roughly $90 to $200 a month. That covers the physician evaluation, sourcing through a licensed 503A pharmacy instead of a chemical supplier, and the testing that comes standard with licensed dispensing. You’re paying for accountability, in whatever form the peptide takes, which is exactly what the gray market doesn’t offer at any price.

What is hexarelin and what does it actually do in the body?

It’s a synthetic six-amino-acid peptide that binds the ghrelin receptor and prompts the pituitary to release growth hormone. It also has direct cardiac and adrenal effects that researchers are still sorting out. Most of what we know comes from small clinical studies, not large trials, so treat the picture as incomplete. It’s a growth hormone secretagogue with a thinner research base than its online reputation would suggest.

What side effects come up most in the human studies?

Elevated cortisol and prolactin show up more consistently here than with a lot of other secretagogues. Water retention, increased hunger, and some transient fatigue get reported too. The cortisol bump is worth taking seriously if you already deal with blood sugar or mood issues. The GH response fading with prolonged daily use is well documented, so cycling isn’t a nice-to-have, it’s a practical necessity based on the data.

Is it even legal to buy and use hexarelin?

It sits in a gray zone in most countries. Neither the FDA nor the EMA has approved it as a drug, so selling it as a finished medicine isn’t legal, but possession laws vary and enforcement against individuals is rare. That gap is exactly where research-chemical sellers operate. If you want any accountability for what you’re getting, a physician-supervised compounding route like FormBlends works under pharmacy regulations requiring identity and purity testing, which street or online sellers simply don’t do.

Does the evidence actually back up what most people want hexarelin to do?

For a short-term GH pulse in healthy adults, the mechanism checks out reasonably well. For fat loss, muscle gain, or recovery as actual outcomes, the human data are thin. Most trials were short, small, and measured hormone levels, not body composition. The mechanism is real. The jump from “raises GH acutely” to “changes how you look or perform” hasn’t been tested the way people assume it has.

References

I matched each source below against its own PubMed or PMC entry before listing it here. Pull up any one of them and confirm it for yourself.

1. CD36 mediates the cardiovascular action of growth hormone-releasing peptides (including hexarelin) in the heart; dose-dependent coronary effects, absent in CD36-null animals. Bodart et al., Circulation Research, 2002. https://pubmed.ncbi.nlm.nih.gov/11988484/
2. Acute hexarelin improved cardiac performance (LV ejection fraction, cardiac output) in 24 coronary artery disease patients during bypass surgery; effect not attributable to growth hormone. Broglio et al., European Journal of Pharmacology, 2002. https://pubmed.ncbi.nlm.nih.gov/12144941/
3. Hexarelin protected rat cardiomyocytes from in vivo ischemia/reperfusion injury through an interleukin-1 signaling pathway. Huang et al., International Heart Journal, 2017.
4. Review of the cardiovascular action of hexarelin, including CD36-mediated cardioprotection; framed as a possible future therapeutic direction. Mao et al., Journal of Geriatric Cardiology, 2014.
5. Hexarelin preserved left-ventricular function and reduced cardiac fibrosis in a mouse model of acute myocardial infarction (no mortality figures reported). McDonald et al., Physiological Reports, 2018.
6. Examined whether desensitization to hexarelin occurs; growth hormone response declined by weeks 4 and 16 of repeated use, but the attenuation was partial and reversible. Rahim & Shalet, Growth Hormone & IGF Research, 1998.
7. Short-term intranasal or oral hexarelin, given intermittently, did not desensitize the growth hormone response in human aging. Ghigo et al., European Journal of Endocrinology, 1996.
8. The growth hormone response to hexarelin is blunted in elderly subjects; arginine and growth-hormone-releasing hormone restore it. Arvat et al., Journal of Clinical Endocrinology and Metabolism, 1994.

Anti-doping note: hexarelin is prohibited in sport at all times under the WADA code as a growth hormone secretagogue. Tested athletes should confirm the current WADA Prohibited List wording before use.

Written by Gia Petrova, independent journalist. Last reviewed April 2026.

This does not replace professional care. Talk with a licensed clinician about your options.